XML 34 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 9 - Shareholders' Equity
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
Note
9.
    Shareholders’ Equity
 
Stock-based Compensation Plans
 
We periodically grant restricted stock unit awards, performance-based share awards and shares of common stock to our employees and directors. We measure compensation cost for restricted stock units and stock grants at the closing price of our stock at the time of grant. We measure compensation cost for performance-based grants using a Monte Carlo simulation to estimate their value at grant date. Restricted stock unit and performance-based share grants vest after a specified period with compensation cost amortized over that period. Although we have
no
current plans to issue stock options, we
may
do so in the future.
 
In
March 2018,
the Board of Directors granted
1,237,369
shares of common stock to employees for payment of long-term incentive compensation for the period ended
December 31, 2017.
The shares were distributed in
March 2018,
and
$4.9
million in expense related to the stock awards was recognized in the periods prior to
March 
31,
2018.
 
In
June
and
August 2018,
the Board of Directors granted the following restricted stock unit awards to employees resulting in a total expense of
$7.0
million:
 
 
1,854,054
restricted stock units, with
one
third
of those vesting in
June 2019,
one
third
vesting in
June 2020,
and
one
third
vesting in
June 2021;
 
96,604
restricted stock units, with
one
half of those vesting in
June 2019
and
one
-half vesting in
June 2020;
and
 
28,721
restricted stock units that vest in
June 2019.
 
An expense of
$2.5
million related to the unit awards discussed above vesting in
2019
will be recognized on a straight-line basis over the
twelve
months following the date of the award. An expense of
$2.4
million related to the unit awards discussed above vesting in
2020
will be recognized on a straight-line basis over the
twenty-four
months following the date of the award. An expense of
$2.2
million related to the unit awards discussed above vesting in
2021
will be recognized on a straight-line basis over the
thirty-six
-month period following the date of the award.
 
In
June 2018,
the Board of Directors granted performance-based share awards to certain executive employees. The value of the awards will be based on the ranking of the market performance of our common stock relative to the performance of the common stock of a group of peer companies over the
three
-year measurement period ending
December 31, 2020.
The number of shares to be issued will be based on the value of the awards divided by the share price at grant date. The expense related to the performance-based awards will be recognized on a straight-line base over the
thirty
months following the date of the award.
 
Stock-based compensation expense for restricted stock unit and performance-based grants to employees and shares issued to nonemployee directors recorded in the
first
nine
months of
2018
totaled
$4.7
million, compared to
$4.9
million in the same period last year.
 
In connection with the vesting of restricted stock units and other stock grants, employees have in the past, at their election and when permitted by us, chosen to satisfy their minimum tax withholding obligations through net share settlement, pursuant to which the Company withholds the number of shares necessary to satisfy such withholding obligations and pays the obligations in cash.  As a result, in the
first
nine
months of
2018
we withheld
697,341
shares valued at approximately
$2.7
million, or approximately
$3.86
per share. In the
first
nine
months of
2017
we withheld
588,240
shares valued at approximately
$3.0
million, or approximately
$5.09
per share.
 
Common Stock Dividends
 
In
September 2011
and
February 2012,
our Board of Directors adopted a common stock dividend policy that has
two
components: (
1
) a dividend that links the amount of dividends on our common stock to our average quarterly realized silver price in the preceding quarter, and (
2
) a minimum annual dividend of
$0.01
per share of common stock, in each case, payable quarterly, if and when declared. For illustrative purposes only, the table below summarizes potential per share dividend amounts at different quarterly average realized price levels according to the
first
component of the policy:
 
Quarterly average realized silver price
per ounce
   
Quarterly dividend
per share
   
Annualized dividend
per share
 
$30    
$0.01
   
$0.04
 
$35    
$0.02
   
$0.08
 
$40    
$0.03
   
$0.12
 
$45    
$0.04
   
$0.16
 
$50    
$0.05
   
$0.20
 
 
 
On
November 6, 2018,
our Board of Directors declared a common stock dividend, pursuant to the minimum annual dividend component of the policy described above, of
$0.0025
per share, for a total dividend of approximately
$1.2
million payable in
December 2018.
Because the average realized silver price for the
third
quarter of
2018
was
$14.68
per ounce, below the minimum threshold of
$30
according to the policy,
no
silver-price-linked component was declared or paid. The declaration and payment of common stock dividends is at the sole discretion of our Board of Directors.
 
At-The-Market Equity Distribution Agreement
 
Pursuant to an equity distribution agreement dated
February 23, 2016,
we
may
issue and sell shares of our common stock from time to time through ordinary broker transactions having an aggregate offering price of up to
$75
million, with the net proceeds available for general corporate purposes. The terms of sales transactions under the agreement, including trading day(s), number of shares sold in the aggregate, number of shares sold per trading day, and the floor selling price per share, are proposed by us to the sales agent. Whether or
not
we engage in sales from time to time
may
depend on a variety of factors, including share price, our cash resources, customary black-out restrictions, and whether we have any material inside information. The agreement can be terminated by us at any time. The shares issued under the equity distribution agreement are registered under the Securities Act of
1933,
as amended, pursuant to our shelf registration statement on Form S-
3,
which was filed with the SEC on
February 23, 2016.
As of
September 
30,
2018,
we had sold
5,634,758
 shares under the agreement for total proceeds of approximately
$20.8
million, net of commissions of approximately
$0.5
million. We sold
1,025,911
shares under the agreement during the
third
quarter of
2018
for total proceeds of
$3.1
million, net of commissions of approximately
$0.1
million.
 
Common Stock Repurchase Program
 
On
May 8, 2012,
we announced that our Board of Directors approved a stock repurchase program.  Under the program, we are authorized to repurchase up to
20
million shares of our outstanding common stock from time to time in open market or privately negotiated transactions, depending on prevailing market conditions and other factors.  The repurchase program
may
be modified, suspended or discontinued by us at any time. Whether or
not
we engage in repurchases from time to time
may
depend on a variety of factors, including
not
only price and cash resources, but customary black-out restrictions, whether we have any material inside information, limitations on share repurchases or cash usage that
may
be imposed by our credit agreement or in connection with issuances of securities, alternative uses for cash, applicable law, and other investment opportunities from time to time. As of
September 
30,
2018,
934,100
shares have been purchased at an average price of
$3.99
per share, leaving approximately
19.1
million shares that
may
yet be purchased under the program. The closing price of our common stock at
November 
6,
2018,
was
$2.49
 per share.
 
Warrants
 
As discussed in
Note
14
, we issued
4,136,000
warrants to purchase
one
share of our common stock to holders of warrants to purchase Klondex common stock under the terms of the Klondex acquisition, and all of the warrants were outstanding as of
September 
30,
2018.
2,068,000
of the warrants have an exercise price of
$8.02
and expire in
April 2032.
2,068,000
of the warrants have an exercise price of
$1.57
and expire in
February 2029.